Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit

• Type of Material: Article
• Authors: M. Citlallu Perez-Guzman, Emory University; Elizabeth Duggan, Emory University; Seid Gibanica, Emory University; Saumeth Cardona, Emory University; Andrea Corujo-Rodriguez, Emory University; Bola Faloye, Emory University; Michael Halkos, Emory University; Guillermo Umpierrez, Emory University; Limin Peng, Emory University; Georgia Davis, Emory University; Francisco Pasquel, Emory University
• Language: English
• Date: 2021-03-01
• Publisher: American Diabetes Association
• Publication Version: Final Published Version
• Copyright Statement: © 2021 by the American Diabetes Association
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.2337/dc20-2386
• Title of Journal or Parent Work: Diabetes Care
• Volume: 44
• Issue: 3
• Start Page: E50
• End Page: E52
• Grant/Funding Information: G.M.D. is supported by NIH under award number 1K23DK122199-01A1.; This study was supported by the National Institute of General Medical Sciences of the National Institutes of Health (NIH) and by an investigator-initiated study grant from Dexcom (F.J.P.).; G.E.U. is partly supported by research grants from the NIH National Center for Advancing Translational Sciences (UL1 TR002378 and 1P30DK111024-05) and has received unrestricted research support from Sanofi, Novo Nordisk, and Dexcom.; F.J.P. is supported in part by NIH under award numbers 1K23GM128221-03, P30DK11102405, and P30DK111024-05S and has received research support from Merck and Dexcom
• Keywords: Science & Technology; Endocrinology & Metabolism; Life Sciences & Biomedicine
• Research Categories: Health Sciences, Medicine and Surgery; Health Sciences, Public Health; Health Sciences, Health Care Management

Abstract

Rapid implementation of remote continuous glucose monitoring (CGM) is occurring across hospitals during the coronavirus disease 2019 (COVID-19) pandemic. Despite limited experience, the U.S. Food and Drug Administration is not objecting to the inpatient use of CGM to limit the exposure of health care workers to severe acute respiratory syndrome coronavirus 2 and to reduce the waste of personal protective equipment (1). Recent efforts in non–intensive care unit (ICU) patients suggest that CGM devices are accurate in the inpatient setting and can help monitor patients remotely (2,3). In addition, two recent small trials enrolling non-ICU patients confirm the feasibility of using remote real-time CGM in the hospital (4,5).